CardioSomatics

SCImago Journal & Country Rank
SciteSore by SCOPUS

Peer-review medical journal

Editor-in-chief

Deputy Editor-in-Chief

Official publication

Publisher

About

CardioSomatics includes many medical scientific and clinical disciplines, as well as issues of organizing and conducting medical rehabilitation (cardiological and cardiosomatic), preventive medicine, public health discipline, which are aimed at maintaining a healthy lifestyle, eliminating the causes of chronic non-infectious and cardiovascular diseases with comorbidity.

The Journal publishes original researches, reviews, clinical studies, clinical guidelines, educational articles, notes and case reports.

The goal is to improve understanding of the pathogenetic mechanisms of disease development, approaches to primary and secondary prevention, medical rehabilitation, diagnostics features, principles of pharmacological and surgical treatment of cardiovascular diseases with cardiac or other somatic comorbidities. An important task of the journal is to improve the quality of researches in the field of fundamental and clinical medicine. This covers different areas of medicine: aspects of pathology, genetics, physiology, electrophysiology, nutrition, pharmacology, rehabilitation, prevention, clinical and social sciences, as well as any disciplines related to the prevention of cardiovascular diseases and somatic comorbidity. Published articles provide researchers and clinicians with the information they need to make decisions in difficult situations.

Research fields

  • Acute coronary syndrome, myocardial infarction and stable coronary artery disease.
  • Disorders of heart rhythm and conduction.
  • Arterial hypertension, pulmonary hypertension.
  • Heart failure and myocarditis.
  • Lipid metabolism disorders and lipid-lowering therapy.
  • Atherosclerotic diseases.
  • Pharmacological treatment of cardiovascular diseases and comorbidity.
  • Risk factors for cardiovascular diseases and other non-infectious chronic diseases.
  • Comorbidities: stroke, pulmonary diseases, diabetes mellitus, prediabetes, obesity and hypothyroidism, nonalcoholic fatty liver disease and other liver diseases, gastrointestinal.
  • diseases, neurological disorders, and kidney diseases.
  • Medical rehabilitation for cardiovascular diseases and comorbidity.
  • Pathophysiological aspects of the impact of exercise training.
  • Genetic aspects of cardiovascular diseases.

Types of accepted articles

  • reviews;
  • systematic reviews and meta-analysis;
  • original study articles;
  • case reports and series of cases;
  • letters to the editor;
  • hystorical articles 

Publication, distribution and indexation

  • Russian and English full-text articles;
  • issues publish quarterly, 4 times per year;
  • no APC, Platinum Open Access
  • articles distributr under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0).

Indexation


Announcements More Announcements...

 

AI in Publishing and Reviewing Articles: A New Editorial Policy

Posted: 24.07.2026

The journal has published a new editorial policy regarding the use of artificial intelligence (AI) technologies by editors, authors, reviewers, and the publisher. This policy sets forth the principles and rules for the use of AI, including for research planning and conduct, the preparation and creation of research materials, including research reports (manuscripts), as well as during manuscript submission to the journal and correspondence with editorial staff and reviewers.

For more information, see the "About" and "Author Guidelines" sections.


 

Current Issue

Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 17, No 1 (2026)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Original study articles

Improving accessibility and quality of outpatient rehabilitation after acute myocardial infarction
Golovenkin S.E., Nikulina S.Y., Bubnova M.G., Savitsky I.V.
Abstract

BACKGROUND: A survey of patients who completed outpatient rehabilitation after acute myocardial infarction (AMI) revealed several deficiencies in the accessibility and quality of this service. A follow-up survey after addressing these deficiencies was conducted to determine the extent of improvement in these parameters.

AIM: To study changes in the accessibility and quality of outpatient rehabilitation based on follow-up survey data from patients who completed rehabilitation after AMI.

METHODS: In 2024, we surveyed 120 patients (98 men, 22 women) who had completed outpatient rehabilitation after AMI using a 20-item questionnaire designed to identify deficiencies in accessibility and quality of care. In 2025, we re-surveyed 120 patients (86 men, 34 women) using the same questionnaire to assess changes in rehabilitation service organization.

RESULTS: In 2025, compared with 2024, there was a significant increase in the number of patients satisfied with the completeness of rehabilitation information provided by their physician (from 99 [82.5%] to 115 [95.8%]; p = 0.001), those who rated physical rehabilitation methods positively (from 98 [81.7%] to 109 [90.8%]; p = 0.039), those who considered lifelong secondary prevention necessary (from 86 [71.7%] to 104 [86.7%]; p = 0.004), and those willing to use telemedicine or wearable digital devices in the future (from 58 [48.3%] to 75 [62.5%]; p = 0.027). Regarding the rehabilitation process, the number of patients reporting difficulty reaching the clinic by phone decreased (from 26 [21.7%] to 12 [10.0%]; p = 0.013), as did the number reporting a waiting list for hospitalization (from 29 [24.2%] to 17 [14.2%]; p = 0.049).

CONCLUSION: These findings suggest that patient surveys can significantly improve the accessibility and quality of outpatient rehabilitation organization after AMI.

CardioSomatics. 2026;17(1):5-15
pages 5-15 views
Clinical and demographic profiles of myocardial infarction in the adult population in 2003 and 2023
Larina V.N., Samorodskaya I.V., Klyuchnikov I.V.
Abstract

BACKGROUND: Given the global trend toward a change in the clinical profile of patients with a history of myocardial infarction, we limited this study to determining the prevalence of myocardial infarction in a representative population sample in 2003 and 2023.

AIM: To investigate the prevalence of myocardial infarction and compare the clinical and demographic profiles of individuals with myocardial infarction based on data from a representative survey of the Russian population in 2003 and 2023.

METHODS: We conducted a retrospective study of data from the Russian Longitudinal Monitoring Survey of Households (RLMS-HSE), a series of annual national representative surveys based on a probability-based stratified multistage territorial sample. In the first stage, we determined the prevalence of myocardial infarction among all respondents in 2003 and 2023. In the second stage, we compared the frequency of arterial hypertension, diabetes mellitus, stroke, smoking, and obesity (body mass index ≥30 kg/m²) between respondents with and without a history of myocardial infarction in both years.

RESULTS: The mean age of respondents was 45.0 ± 17.8 years in 2003 and 50.7 ± 17.1 years in 2023 (p < 0.001). The prevalence of self-reported myocardial infarction was 2.7% in 2003 and 2.2% in 2023 (p < 0.01). The frequency of self-reported myocardial infarction differed between 2003 and 2023 across three age groups by sex. Among men under 45 years, the difference was significant (p = 0.01), but not among women (p = 0.5). In the 45–60 age group, the difference was significant for both men (p = 0.001) and women (p = 0.014). Similarly, in the over-60 group, the difference was significant for men (p = 0.009) and women (p = 0.049). Among respondents without myocardial infarction over 60 years, smoking prevalence increased slightly (from 13.5% to 14.5%); in the 45–60 group, the decline in smoking was marginal (from 34.6% to 32.8%).

CONCLUSION: The results indicate a decrease in myocardial infarction prevalence among both men and women, alongside an increase in mean age, diabetes prevalence, and stroke history among respondents with myocardial infarction.

CardioSomatics. 2026;17(1):16-25
pages 16-25 views
Associations of triglycerides with other cardiometabolic syndrome parameters in patients with hypertriglyceridemia
Shomin A.V., Serezhina E.K., Obrezan A.G.
Abstract

BACKGROUND: Triglycerides are a key component of lipid metabolism and play an important role in the development of cardiometabolic syndrome, a cluster of cardiovascular risk factors. Identifying correlations between triglyceride levels and other cardiometabolic parameters has great scientific and practical value.

AIM: To study the correlations between triglycerides and other cardiometabolic parameters in patients with hypertriglyceridemia.

METHODS: This retrospective study included 693 cardiovascular patients aged 18 to 90 years with hypertriglyceridemia. Spearman rank correlation coefficient was used to assess correlations, and the strength of associations was interpreted using Chaddock scale.

RESULTS: Significant correlations between triglycerides and the following cardiometabolic parameters were found: body weight (r = 0.21, p < 0.001), body mass index (r = 0.23, p < 0.001), visceral fat index (r = 0.784, p < 0.001), waist circumference (r = 0.111, p = 0.045), METS-IR index (r = 0.358, p < 0.001), plasma atherogenicity index (r = 0.815, p < 0.001), glucose (r = 0.142, p = 0.001), HOMA-IR index (r = 0.20, p = 0.004), fasting insulin (r = 0.471, p < 0.001), total cholesterol (r = 0.265, p < 0.001), high-density lipoprotein cholesterol (r = −0.266, p < 0.001), very low-density lipoprotein cholesterol (r = 0.965, p < 0.001), remnant cholesterol (r = 0.511, p < 0.001), and uric acid (r = 0.189, p < 0.001).

CONCLUSION: Triglycerides are key to the pathogenesis of cardiometabolic syndrome, interacting with other components through complex lipid and carbohydrate metabolic pathways. Elevated serum triglyceride levels are associated with abdominal obesity, type 2 diabetes mellitus, and arterial hypertension. Hypertriglyceridemia is also associated with elevated blood pressure, total cholesterol, and very low-density lipoprotein levels. Triglycerides correlate with all components of cardiometabolic syndrome, most likely through insulin resistance, which should be considered in the comprehensive management of these patients. Further research in this area is needed.

CardioSomatics. 2026;17(1):26-40
pages 26-40 views

Reviews

Current challenges in the organization of pediatric resuscitation: a review
Megeryan M.M., Abramov A.Y., Degtyareva E.A.
Abstract

This paper presents a narrative review of Russian and international studies on the current problems in the organization of pediatric resuscitation and potential solutions. We characterize the causes of acute and chronic critical illnesses in children that require admission to the intensive care unit. Significant progress has been made in pediatric critical care: whereas the previous goal was to reduce mortality in pediatric patients, the current priority is improving the quality of life of surviving children and their families.

However, several key issues remain debated: optimal indications for extracorporeal cardiopulmonary resuscitation, choice of infusion solutions and pharmacotherapy in neonatal resuscitation, and standardization of nutritional support and sedation protocols. The number of children with chronic critical illnesses has increased; their prolonged ICU stays are associated with higher healthcare costs and worse outcomes. A systematic, multidisciplinary approach, supported by international and national clinical guidelines and diagnostic algorithms, is essential. Synthesis of the available data helps identify priority areas for further research on the organization of pediatric critical care. This review may be of interest to critical care physicians, pediatricians, and healthcare administrators.

CardioSomatics. 2026;17(1):41-50
pages 41-50 views
Modern perspectives on the role of the interferon system in the pathogenesis and therapy of cardiovascular complications of viral infections: an analytical review
Degtyareva E.A., Kufa M.A., Megeryan M.M.
Abstract

This paper presents an analytical review of Russian and international studies published between 2021 and 2025, critically examining the role of the interferon (IFN) system in cardiovascular protection during viral infections. In the current epidemiological context, characterized by the “tridemic” phenomenon (concurrent circulation of influenza, SARS-CoV-2, and RSV), the risk of virus-induced cardiac damage—including myocarditis, arrhythmias, and endothelial dysfunction—remains highly relevant. The review analyzes two leading pathogenetic concepts for these complications: direct cytolytic cardiomyocyte injury and immune-mediated damage resulting from the “interferon pause”—a failure of innate immune sensors (the MDA5–MAVS axis). This mechanism is considered a key trigger of the systemic inflammatory response and multisystem inflammatory syndrome. Recent clinical trials and meta-analyses of interferon therapy effectiveness are reviewed in detail, showing that clinical outcomes depend heavily on adherence to the “therapeutic window” (the first 72 hours of illness). Special attention is given to the Russian experience with a fixed-dose combination of recombinant IFN-α-2b and antioxidants (vitamins E and C). The biochemical mechanisms by which this approach may reduce oxidative stress and overcome cellular receptor resistance are discussed—of particular importance in children who have physiological immaturity of interferon production. The review concludes by outlining the most evidence-based, controversial, and under-investigated aspects of interferon use for cardioprotection. This review is intended for pediatricians, cardiologists, infectious disease specialists, and healthcare administrators.

CardioSomatics. 2026;17(1):51-60
pages 51-60 views

Case reports

A case of recurrent pericarditis
Vybach M.V., Koryakova N.V., Vezikova N.N., Ryabkov V.A., Polskaya I.I.
Abstract

BACKGROUND: Recurrent pericarditis requires a comprehensive evaluation to rule out infectious, autoimmune, and oncological conditions. Idiopathic recurrent pericarditis is considered an autoinflammatory disease and is not characterized by specific immunological disorders, particularly autoantibody production. Given the rarity of true idiopathic pericarditis, a thorough search for an underlying cause is essential, especially when markers suggestive of autoimmune or malignant disease are present.

CASE DESCRIPTION: We present a case of recurrent pericarditis in an elderly male patient. The case is notable for repeated detection of immunological markers typical of systemic connective tissue diseases, along with recurrent lymphadenopathy. Despite ongoing follow-up, no specific underlying etiology could be identified, and the diagnosis was established as idiopathic recurrent pericarditis. With continuous colchicine therapy at 1 mg/day for 6 months, no further pericarditis recurrences occurred. The patient tolerates the treatment well, and no adverse effects have been reported. Follow-up is ongoing.

CONCLUSION: This case highlights the diagnostic challenges of recurrent pericarditis and underscores the need for a multidisciplinary approach involving cardiologists, rheumatologists, oncologists, and other specialists.

CardioSomatics. 2026;17(1):61-69
pages 61-69 views